Insider Transactions last 24 months for Karyopharm Therapeutics Inc.  -  NSDQ: KPTI

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Paulson Richard A.President and CEO03/02/2026DSDirectCOM12,361$9.41$116,310.83267,030
Rangwala ReshmaEVP & Chief Medical Officer03/02/2026DSDirectCOM5,066$9.41$47,668.5356,739
Mano MichaelEVP, CLO&Secretary03/02/2026DSDirectCOM3,526$9.41$33,177.9093,964
Cheng Sohanya RoshanEVP & Chief Commercial Officer03/02/2026DSDirectCOM4,604$9.41$43,321.34107,317
Poulton StuartEVP, Chief Development Officer03/02/2026DSDirectCOM5,101$9.41$47,997.8694,328
Abate KristinChief Accounting Officer03/02/2026DSDirectCOM559$9.41$5,259.9122,063
Poulton StuartEVP, Chief Development Officer02/17/2026DSDirectCOM378$8.63$3,262.1499,429
Paulson Richard A.President and CEO02/05/2026AADirectCOM81,060$0.00$0.00279,391
Macomber LoriEVP, CFO & Treasurer02/03/2026DSDirectCOM1,626$6.30$10,243.8085,105
Poulton StuartEVP, Chief Development Officer01/31/2026AADirectCOM32,415$0.00$0.0099,807
Mano MichaelEVP, CLO&Secretary01/31/2026AADirectCOM32,415$0.00$0.0097,490
Macomber LoriEVP, CFO & Treasurer01/31/2026AADirectCOM32,415$0.00$0.0086,731
Rangwala ReshmaEVP & Chief Medical Officer01/31/2026AADirectCOM32,415$0.00$0.0061,805
Cheng Sohanya RoshanEVP & Chief Commercial Officer01/31/2026AADirectCOM32,415$0.00$0.00111,921
Abate KristinChief Accounting Officer01/28/2026DSDirectCOM50$7.03$351.5022,622
Abate KristinChief Accounting Officer01/27/2026AADirectCOM92$0.00$0.0022,672
Abate KristinChief Accounting Officer01/21/2026DSDirectCOM265$5.96$1,579.4022,580
Macomber LoriEVP, CFO & Treasurer10/15/2025AADirectCOM43,650$0.00$0.0054,316
Cheng Sohanya RoshanEVP & Chief Commercial Officer10/15/2025AADirectCOM43,650$0.00$0.0079,506
Paulson Richard A.President and CEO10/15/2025AADirectCOM114,285$0.00$0.00198,331
Mano MichaelSVP, General Counsel&Secretary10/15/2025AADirectCOM43,650$0.00$0.0065,075
Poulton StuartEVP, Chief Development Officer10/15/2025AADirectCOM39,682$0.00$0.0067,392
Abate KristinChief Accounting Officer10/15/2025AADirectCOM12,799$0.00$0.0022,845
Abate KristinChief Accounting Officer10/01/2025DSDirectCOM362$6.30$2,279.1510,046
Abate KristinChief Accounting Officer09/15/2025DSDirectCOM23$6.43$147.8910,408
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel